Literature DB >> 438303

Growth of human embryonic fibroblasts at clonal density: concordance with results from mass cultures.

J R Smith, K I Braunschweiger.   

Abstract

In the past, it has been difficult to grow human diploid fibroblast cells at clonal densities. Newly devised cell culture media and rigorously controlled environmental conditions have greatly increased the ease with which such cells can be cloned. The present work was undertaken to determine whether, under appropriate conditions, diploid fibroblast cells from human embryonic lung, grow as well at clonal densities as in mass culture. The parameters studied were: (1) population doubling time, (2) in vitro proliferative capacity, (3) attachment, (4) percentage of non-dividing cells. In all cases essentially the same results were obtained for cultures at clonal densities and mass cultures. These results indicate that the behavior of these types of cells in clonal culture can be used to infer the behavior of individual cells and clones within a mass culture.

Entities:  

Mesh:

Year:  1979        PMID: 438303     DOI: 10.1002/jcp.1040980317

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

1.  Seeding efficiency, plating efficiency, and population doublings of human skin fibroblastlike cells: results of replicate testing.

Authors:  R Vracko; B H McFarland; R E Pecoraro
Journal:  In Vitro       Date:  1983-06

2.  Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA).

Authors:  Kazuo Yudoh; Rie Karasawa
Journal:  Aging (Albany NY)       Date:  2010-12       Impact factor: 5.682

3.  Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function.

Authors:  Kazuo Yudoh; van Trieu Nguyen; Hiroshi Nakamura; Kayo Hongo-Masuko; Tomohiro Kato; Kusuki Nishioka
Journal:  Arthritis Res Ther       Date:  2005-01-26       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.